Department of Medical Biochemistry and Microbiology, University of Uppsala, BMC, Husargatan 3, 75237, Uppsala, Sweden.
The Racah Institute of Physics, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem, 9190401, Jerusalem, Israel.
FEMS Microbiol Rev. 2020 Mar 1;44(2):171-188. doi: 10.1093/femsre/fuaa001.
Antibiotic resistance is one of the major challenges facing modern medicine worldwide. The past few decades have witnessed rapid progress in our understanding of the multiple factors that affect the emergence and spread of antibiotic resistance at the population level and the level of the individual patient. However, the process of translating this progress into health policy and clinical practice has been slow. Here, we attempt to consolidate current knowledge about the evolution and ecology of antibiotic resistance into a roadmap for future research as well as clinical and environmental control of antibiotic resistance. At the population level, we examine emergence, transmission and dissemination of antibiotic resistance, and at the patient level, we examine adaptation involving bacterial physiology and host resilience. Finally, we describe new approaches and technologies for improving diagnosis and treatment and minimizing the spread of resistance.
抗生素耐药性是全球现代医学面临的主要挑战之一。在过去的几十年中,我们对影响抗生素耐药性在人群水平和个体患者水平出现和传播的多种因素的理解取得了快速进展。然而,将这一进展转化为卫生政策和临床实践的过程一直很缓慢。在这里,我们试图将有关抗生素耐药性的进化和生态学的现有知识整合到一个路线图中,以指导未来的研究以及对抗生素耐药性的临床和环境控制。在人群水平上,我们研究抗生素耐药性的出现、传播和扩散;在个体患者水平上,我们研究涉及细菌生理学和宿主弹性的适应性。最后,我们描述了改进诊断和治疗以及最小化耐药性传播的新方法和技术。